CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- CORRESP Other Correspondence Between Filers and SEC Staff
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Sr. Vice President and COO sold 120,312 shares at $2.50 ($300,816)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Unregistered share sale
- 4/A Planned sale Sr. Vice President and COO sold 185,937 shares at an average $1.76 ($328,104)
- 4 Planned sale Sr. Vice President and COO sold 181,219 shares at $2.00 ($362,438)
- 144 Insider Sale of Securities
- 4 Planned sale Sr. Vice President and COO sold 185,937 shares at an average $1.76 ($328,104)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Principal Accounting Officer sold 6,533 shares at $1.29 ($8,428)
- 144 Insider Sale of Securities
- 4 Planned sale Sr. Vice President and COO sold 100,000 shares at $1.50 ($150,000)
- 144 Insider Sale of Securities
- 4 Planned sale Sr. Vice President and COO sold 35,704 shares at an average $1.33 ($47,486)
- 144 Insider Sale of Securities
Page 3 of 24 · 468 filings